CVE-2022-47376 json
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation.
published 2023-06-13 3 y ago modified 2026-06-17 4 mo ago also EUVD-2022-50143
- cvss
- 7.3
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.2%
- EPSS 0.2% chance of exploitation in 30 days, percentile 5%
- public exploits
- 0
- none known
Summary
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
Vendor advisories
What the vendors themselves say about their products: affected, fixed or not affected, and what to do.
cisa ICSMA-23-047-01 updated cvss 7.3
BD Alaris Infusion Central
-
Becton, Dickinson and Company (BD) Alaris Infusion Central software >= 1.1, <= 1.3.2affected: vendor fix, mitigation “Change passwords periodically per best security practice.” bd.com
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- total
- Assessed
- 22 mo ago
Exploit prediction
0.16% chance of exploitation in the next 30 days, higher than 5% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CISA ADP | 3.1 | 7.3 | CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L |
| NVD | 3.1 | 7.3 | CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L |
| CNA | 3.1 | 7.3 | CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L |
Affected products
- n/a Alaris Infusion Central
Classification
References
Sources
- CVE List CVE-2022-47376
- NVD CVE-2022-47376
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.